Prevention and Treatment of Age-related Ovarian Hypofunction with Traditional Chinese Medicine： A Review

JIA Zhicheng; LI Yongqian; WANG Peixuan; LIU Yang; JU Wenhan; LIAN Fang; SUN Zhengao; GUO ying

doi:10.13422/j.cnki.syfjx.20231595

您当前的位置：

首页 >

文章列表页 >

Prevention and Treatment of Age-related Ovarian Hypofunction with Traditional Chinese Medicine： A Review

更新时间：2023-04-28

- Prevention and Treatment of Age-related Ovarian Hypofunction with Traditional Chinese Medicine： A Review
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 11, Pages: 255-265(2023)
- 作者机构：
  
  1.山东中医药大学第一临床医学院，济南 250014
  2.山东中医药大学中医学院，济南 250014
  3.山东中医药大学附属医院，济南 250011
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20231595
  CLC： R242;R856.2;R587.1;R255.4
- Published：05 June 2023，
  
  Published Online：16 February 2023，
  
  Received：16 November 2022，
- 稿件说明：
扫描看全文
贾志诚,李永谦,王培璇等.中药缓解年龄相关卵巢功能减退的研究进展[J].中国实验方剂学杂志,2023,29(11):255-265.

JIA Zhicheng,LI Yongqian,WANG Peixuan,et al.Prevention and Treatment of Age-related Ovarian Hypofunction with Traditional Chinese Medicine： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(11):255-265.
贾志诚,李永谦,王培璇等.中药缓解年龄相关卵巢功能减退的研究进展[J].中国实验方剂学杂志,2023,29(11):255-265. DOI： 10.13422/j.cnki.syfjx.20231595.

JIA Zhicheng,LI Yongqian,WANG Peixuan,et al.Prevention and Treatment of Age-related Ovarian Hypofunction with Traditional Chinese Medicine： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(11):255-265. DOI： 10.13422/j.cnki.syfjx.20231595.

摘要

年龄相关的卵巢功能减退包括了卵泡数量、质量的下降及卵巢微环境的改变，其机制主要与线粒体功能障碍、自由基与抗氧化系统、端粒及端粒酶改变、细胞凋亡等有关，是造成高龄女性不孕症的主要因素之一。尽管生殖医学领域在近几十年取得巨大进步，但在缓解年龄相关的卵巢功能减退和改善高龄女性生殖结局方面却几乎没有取得任何突破性进展。近年来，中医药通过调整线粒体稳态、缓解氧化应激及抑制细胞凋亡等多层次、多靶点作用机制改善年龄相关的卵巢功能减退的研究越来越多，同时，较多高质量的随机对照试验证明了中医药在辅助生殖领域的临床疗效。鉴于此，该文依据近年来中药活性成分、单味中药和中药复方在延缓年龄相关卵巢功能减退的作用机制研究及随机对照试验取得的进展进行系统综述，明确其研究现状和不足，为有效缓解年龄相关的卵巢功能减退和改善高龄女性生育结局提供中医药临床用药思路。

Abstract

Age-related ovarian hypofunction includes a decrease in follicle quantity and quality as well as alterations in the ovarian microenvironment，the mechanisms of which are mainly related to mitochondrial dysfunction，free radical and antioxidant systems，telomere and telomerase alterations，and apoptosis，and is one of the major factors contributing to infertility in advanced maternal age （AMA）. Despite the tremendous progress in assisted reproductive technology in recent decades，few breakthroughs have been made in alleviating age-related ovarian hypofunction and improving reproductive outcomes for AMA. In recent years，there has been an increasing number of studies on the multi-level and multi-targeted mechanisms of traditional Chinese medicine （TCM） to improve age-related ovarian hypofunction by modulating mitochondrial homeostasis，alleviating oxidative stress，and inhibiting apoptosis，while more high-quality randomized controlled trials have demonstrated the clinical efficacy of TCM in assisted reproductive technology. Given this，this article presented a systematic review of recent research and randomized controlled trials on the mechanism of Chinese medicine active ingredients，single Chinese medicine， and Chinese medicine compounds in delaying age-related ovarian hypofunction，to clarify the current status and shortcomings of the research. This paper provides medication management of TCM for effectively alleviating age-related ovarian hypofunction and improving reproductive outcomes for AMA.

关键词

卵巢功能减退不孕症高龄产妇中药“三孩”政策

Keywords

decreased ovarian reserveinfertilityadvanced maternal ageChinese medicinethe three-child policy

references

SUN H，GONG T T，JIANG Y T，et al.Global，regional，and national prevalence and disability-adjusted life-years for infertility in 195 countries and territories，1990-2017：Results from a global burden of disease study，2017［J］.Aging （Albany NY），2019，11（23）：10952-10991.

PINHEIRO R L，AREIA A L，MOTA PINTO A，et al.Advanced maternal age：Adverse outcomes of pregnancy，a Meta-analysis［J］.Acta Med Port，2019，32（3）：219-226.

WANG S，ZHENG Y，LI J，et al.Single-cell transcriptomic atlas of primate ovarian aging［J］.Cell，2020，180（3）：585-600.

RUSS J E，HAYWOOD M E，LANE S L，et al.Spatially resolved transcriptomic profiling of ovarian aging in mice［J］.iScience，2022，25（8）：104819.

RUTH K S，DAY F R，HUSSAIN J，et al.Genetic insights into biological mechanisms governing human ovarian ageing［J］.Nature，2021，596（7872）：393-397.

FOUKS Y，PENZIAS A，NEUHAUSSER W，et al.A diagnosis of diminished ovarian reserve does not impact embryo aneuploidy or live birth rates compared to patients with normal ovarian reserve［J］.Fertil Steril，2022，118（3）：504-512.

CHRISTENSEN M W，KESMODEL U S，CHRISTENSEN K，et al.Early ovarian ageing：Is a low number of oocytes harvested in young women associated with an earlier and increased risk of age-related diseases？［J］.Hum Reprod，2020，35（10）：2375-2390.

JING W，LIU J，MA Q，et al.Fertility intentions to have a second or third child under China's three-child policy：A national cross-sectional study［J］.Hum Reprod，2022，37（8）：1907-1918.

LI H，NAWSHERWAN，FAN C，et al.The trend in delayed childbearing and its potential consequences on pregnancy outcomes：A single center 9-years retrospective cohort study in Hubei，China［J］.BMC Pregnancy Childbirth，2022，22（1）：514.

蒋励，陈耀龙，罗旭飞等.中国高龄不孕女性辅助生殖临床实践指南［J］.中国循证医学杂志，2019，19（3）：253-270.

UBALDI F M，CIMADOMO D，VAIARELLI A，et al.Advanced maternal age in IVF：Still a challenge？ The present and the future of its treatment［J］.Front Endocrinol （Lausanne），2019，10：94.

李今庸.《素问》“女子七七”、“男子八八”解［J］.湖北中医杂志，1982（1）：31.

孙爱军，唐旭东，张巧利，等.卵巢储备功能降低不孕症中西医结合治疗的理论与临床试验研究探讨［J］.中国实验方剂学杂志，2019，25（8）：148-157.

FENG J，WANG J，ZHANG Y，et al.The efficacy of complementary and alternative medicine in the treatment of female infertility［J］.Evid Based Complement Alternat Med，2021，2021：6634309.

CHIANG J L，SHUKLA P，PAGIDAS K，et al.Mitochondria in ovarian aging and reproductive longevity［J］.Ageing Res Rev，2020，63：101168.

LIM J，LUDERER U.Oxidative damage increases and antioxidant gene expression decreases with aging in the mouse ovary［J］.Biol Reprod，2011，84（4）：775-782.

SHOUBRIDGE E A，WAI T.Mitochondrial DNA and the mammalian oocyte［J］.Curr Top Dev Biol，2007，77：87-111.

BONOMI M，SOMIGLIANA E，CACCIATORE C，et al.Blood cell mitochondrial DNA content and premature ovarian aging［J］.PLoS One，2012，7（8）：e42423.

CECCHINO G N，GARCIA-VELASCO J A.Mitochondrial DNA copy number as a predictor of embryo viability［J］.Fertil Steril，2019，111（2）：205-211.

SEBASTIÁN D，PALACÍN M，ZORZANO A.Mitochondrial dynamics：Coupling mitochondrial fitness with healthy aging［J］.Trends Mol Med，2017，23（3）：201-215.

ISHIHARA T，KOHNO H，ISHIHARA N.Physiological roles of mitochondrial fission in cultured cells and mouse development［J］.Ann N Y Acad Sci，2015，1350：77-81.

UDAGAWA O，ISHIHARA T，MAEDA M，et al.Mitochondrial fission factor Drp1 maintains oocyte quality via dynamic rearrangement of multiple organelles［J］.Curr Biol，2014，24（20）：2451-2458.

DIZDAROGLU M，JARUGA P.Mechanisms of free radical-induced damage to DNA［J］.Free Radic Res，2012，46（4）：382-419.

SUGINO N.Reactive oxygen species in ovarian physiology［J］.Reprod Med Biol，2005，4（1）：31-44.

BISWAS S K.Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox？［J］.Oxid Med Cell Longev，2016，2016：5698931.

WANG S，HE G，CHEN M，et al.The role of antioxidant enzymes in the ovaries［J］.Oxid Med Cell Longev，2017，2017：4371714.

SHI L，ZHANG J，LAI Z，et al.Long-term moderate oxidative stress decreased ovarian reproductive function by reducing follicle quality and progesterone production［J］.PLoS One，2016，11（9）：e0162194.

ZHANG X，WU X Q，LU S，et al.Deficit of mitochondria-derived ATP during oxidative stress impairs mouse MII oocyte spindles［J］.Cell Res，2006，16（10）：841-850.

KALMBACH K H，ANTUNES D M，KOHLRAUSCH F，et al.Telomeres and female reproductive aging［J］.Semin Reprod Med，2015，33（6）：389-395.

COLUZZI E，LEONE S，SGURA A.Oxidative stress induces telomere dysfunction and senescence by replication fork arrest［J］.Cells，2019，8（1）：19.

TARDAT M，DÉJARDIN J.Telomere chromatin establishment and its maintenance during mammalian development［J］.Chromosoma，2018，127（1）：3-18.

CHENG E H，CHEN S U，LEE T H，et al.Evaluation of telomere length in cumulus cells as a potential biomarker of oocyte and embryo quality［J］.Hum Reprod，2013，28（4）：929-936.

KEEFE D L，LIU L，MARQUARD K.Telomeres and aging-related meiotic dysfunction in women［J］.Cell Mol Life Sci，2007，64（2）：139-143.

YAMADA-FUKUNAGA T，YAMADA M，HAMATANI T，et al.Age-associated telomere shortening in mouse oocytes［J］.Reprod Biol Endocrinol，2013，11：108.

KEEFE D L.Telomeres and genomic instability during early development［J］.Eur J Med Genet，2020，63（2）：103638.

SADRAIE S H，SAITO H，KANEKO T，et al.Effects of aging on ovarian fecundity in terms of the incidence of apoptotic granulosa cells［J］.J Assist Reprod Genet，2000，17（3）：168-173.

YANG H，XIE Y，YANG D，et al.Oxidative stress-induced apoptosis in granulosa cells involves JNK，p53 and Puma［J］.Oncotarget，2017，8（15）：25310-25322.

TESARIK J，GALÁN-LÁZARO M，MENDOZA-TESARIK R.Ovarian aging：Molecular mechanisms and medical management［J］.Int J Mol Sci，2021，22（3）：1371.

PASQUARIELLO R，VERDILE N，BREVINI T，et al.The role of resveratrol in mammalian reproduction［J］.Molecules，2020，25（19）：4554.

CHEN M，HE C，ZHU K，et al.Resveratrol ameliorates polycystic ovary syndrome via transzonal projections within oocyte-granulosa cell communication［J］.Theranostics，2022，12（2）：782-795.

WU M，MA L，XUE L，et al.Resveratrol alleviates chemotherapy-induced oogonial stem cell apoptosis and ovarian aging in mice［J］.Aging （Albany NY），2019，11（3）：1030-1044.

LIU M，YIN Y，YE X，et al.Resveratrol protects against age-associated infertility in mice［J］.Hum Reprod，2013，28（3）：707-717.

BEAZLEY K E，NURMINSKAYA M.Effects of dietary quercetin on female fertility in mice：Implication of transglutaminase 2［J］.Reprod Fertil Dev，2016，28（7）：974-981.

WANG J，QIAN X，GAO Q，et al.Quercetin increases the antioxidant capacity of the ovary in menopausal rats and in ovarian granulosa cell culture in vitro［J］.J Ovarian Res，2018，11（1）：51.

CHEN Z Z，GONG X.Tanshinone ⅡA contributes to the pathogenesis of endometriosis via renin angiotensin system by regulating the dorsal root ganglion axon sprouting［J］.Life Sci，2020，240：117085.

BAI L，HE G，GAO C，et al.Tanshinone ⅡA enhances the ovarian reserve and attenuates ovarian oxidative stress in aged mice［J］.Vet Med Sci，2022，8（4）：1617-1625.

QI X，LI H，CONG X，et al.Baicalin increases developmental competence of mouse embryos in vitro by inhibiting cellular apoptosis and modulating HSP70 and DNMT expression［J］.J Reprod Dev，2016，62（6）：561-569.

ZHONG X H，ZHOU Z X，LI T S，et al.Anti-abortive effect of Radix scutellariae and Rhizoma atractylodis in mice［J］.Am J Chin Med，2002，30（1）：109-117.

FAN H，HE J，BAI Y，et al.Baicalin improves the functions of granulosa cells and the ovary in aged mice through the mTOR signaling pathway［J］.J Ovarian Res，2022，15（1）：34.

HE J，YAO G，HE Q，et al.Theaflavin 3，3'-digallate delays ovarian aging by improving oocyte quality and regulating granulosa cell function［J］.Oxid Med Cell Longev，2021，2021：7064179.

LEUNG L K，SU Y，CHEN R，et al.Theaflavins in black tea and catechins in green tea are equally effective antioxidants［J］.J Nutr，2001，131（9）：2248-2251.

LUO L L，HUANG J，FU Y C，et al.Effects of tea polyphenols on ovarian development in rats［J］.J Endocrinol Invest，2008，31（12）：1110-1118.

GAO Y，RANKIN G O，TU Y，et al.Theaflavin-3，3′-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways，not via MAPK pathways［J］.Int J Oncol，2016，48（1）：281-292.

TU Y，KIM E，GAO Y，et al.Theaflavin-3，3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells［J］.Int J Oncol，2016，48（6）：2657-2665.

HE X，WANG Y，WU M，et al.Secoisolariciresinol diglucoside improves ovarian reserve in aging mouse by inhibiting oxidative stress［J］.Front Mol Biosci，2021，8：806412.

SETCHELL K D，BROWN N M，ZIMMER-NECHEMIAS L，et al.Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans［J］.Food Funct，2014，5（3）：491-501.

ZHU L，LI J，XING N，et al.American ginseng regulates gene expression to protect against premature ovarian failure in rats［J］.Biomed Res Int，2015，2015：767124.

CHEI S，OH H J，JANG H，et al.Korean red Ginseng suppresses the expression of oxidative stress response and NLRP3 inflammasome genes in aged C57BL/6 mouse ovaries［J］.Foods，2020，9（4）：526.

LI C，LIN L M，SUI F，et al.Chemistry and pharmacology of Siraitia grosvenorii：A review［J］.Chin J Nat Med，2014，12（2）：89-102.

DU Y，LIU J，LIU S，et al.Mogroside-rich extract from Siraitia grosvenorii fruits protects against the depletion of ovarian reserves in aging mice by ameliorating inflammatory stress［J］.Food Funct，2022，13（1）：121-130.

WU Y Y，LIANG C Y，LIU T T，et al.Protective roles and mechanisms of polysaccharides from Dendrobium officinal on natural aging-induced premature ovarian failure［J］.Biomed Pharmacother，2018，101：953-960.

JIA W，WANG X，XU D，et al.Common traditional Chinese medicinal herbs for dysmenorrhea［J］.Phytother Res，2006，20（10）：819-824.

ONG M，CHENG J，JIN X，et al.Paeoniflorin extract reverses dexamethasone-induced testosterone over-secretion through downregulation of cytochrome P450 17A1 expression in primary murine theca cells［J］.J Ethnopharmacol，2019，229：97-103.

PARK M J，HAN S E，KIM H J，et al.Paeonia lactiflora improves ovarian function and oocyte quality in aged female mice［J］.Anim Reprod，2020，17（2）：e20200013.

CHEN C，ZHOU M，GE Y，et al.SIRT1 and aging related signaling pathways［J］.Mech Ageing Dev，2020，187：111215.

刘洋，何川，江威，等.苗药天门冬对衰老大鼠卵巢保护作用［J］.辽宁中医杂志，2019，46（2）：366-369.

杨振博，姚建平，封银曼，等.左归丸治疗老年疾病的研究进展［J］.中国中医药现代远程教育，2018，16（4）：146-149.

赵新永，孙岩，赵鸿森，等.左归丸对自然衰老小鼠卵母细胞线粒体功能的改善作用［J］.中药新药与临床药理，2020，31（8）：924-929.

YANG Z，WEI M L，DONG X Y.Effects of Yu Linzhu on ovarian function and oocyte mitochondria in natural aging mice［J］.Aging （Albany NY），2021，13（19）：23328-23337.

WANG Y，LOU X T，SHI Y H，et al.Erxian decoction，a Chinese herbal formula，for menopausal syndrome：An updated systematic review［J］.J Ethnopharmacol，2019，234：8-20.

赵新永，王丽君，周飞.二仙汤对自然衰老小鼠卵巢颗粒细胞线粒体的改善作用［J］.中药药理与临床，2019，35（4）：10-14.

王海丹，朱萱萱.不同浓度补肾健脾方对卵巢颗粒细胞增殖作用的影响［J］.河南中医，2017，37（6）：1005-1007.

王海丹，陆葳，郭红玉，等.补肾健脾对自然衰老小鼠卵巢端粒的调控作用［J］.中华中医药杂志，2021，36（9）：5191-5194.

李然，郭颖.基于网络药理学及分子对接探讨二至天癸方治疗女性不孕症的作用机制［J］.中国药理学通报，2022，38（1）：126-133.

郭颖，连方.二至天癸颗粒对初老小鼠胚胎线粒体膜电位及发育潜能的影响［J］.山东医药，2016，56（42）：43-45.

付寒雪，赵嘉静，黄文玲.基于AMPK/PGC-1α信号通路探讨乌萸汤对初老小鼠卵母细胞的作用机制［J］.现代中西医结合杂志，2022，31（12）：1624-1629.

郑凌琦，黄文玲，刘艳霞，等.乌萸汤对高龄小鼠卵母细胞的能量代谢相关影响［J］.环球中医药，2021，14（6）：1020-1027.

辛明蔚，何军琴，贾朝霞，等.温肾养血方提高高龄雌鼠卵母细胞质量和胚胎发育潜能的研究［J］.首都医科大学学报，2018，39（6）：815-820.

KIM J，YOU S.Samul-tang ameliorates oocyte damage due to cyclophosphamide-induced chronic ovarian dysfunction in mice［J］.Sci Rep，2020，10（1）：21925.

KIM J，YOU S.Effect of samul-tang on female fertility via RAS signaling pathway in ovaries of aged mice［J］.Aging （Albany NY），2021，13（11）：14829-14842.

No authors listeel .Infertility workup for the women's health specialist：ACOG committee opinion，number 781［J］.Obstet Gynecol，2019，133（6）：e377-e384.

DONG M，SUN L，HUANG L，et al.Gonadotropin-releasing hormone agonist combined with hormone replacement therapy does not improve the reproductive outcomes of frozen-thawed embryo transfer cycle in elderly patients：A retrospective study［J］.Reprod Biol Endocrinol，2020，18（1）：73.

JINNO M，NAGAI R，TAKEUCHI M，et al.Trapa bispinosa Roxb.extract lowers advanced glycation end-products and increases live births in older patients with assisted reproductive technology：A randomized controlled trial［J］.Reprod Biol Endocrinol，2021，19（1）：149.

连方，相珊.二至天癸方对IVF-ET患者颗粒细胞凋亡的影响［J］.中国中西医结合杂志，2017，37（11）：1315-1319.

李明.二至天癸颗粒对肾气阴两虚型高龄IVF-ET患者卵泡液RBP-4及颗粒细胞AnnexinA5的影响［D］.济南：山东中医药大学，2016.

宫政，从c-FLIP因子观察二至天癸颗粒对卵巢颗粒细胞凋亡的影响［D］.济南：山东中医药大学，2016.

李婷婷，二至天癸颗粒对卵泡颗粒细胞Fas通路的影响［D］.济南：山东中医药大学，2016.

杨欢，二至天癸颗粒对IVF-ET患者卵泡液颗粒细胞TGFβ1 mRNA表达的影响［D］.济南：山东中医药大学，2013.

李冉，基于TGF-β/Smads通路探讨补肾中药对高龄肾阴虚型IVF患者卵细胞质量的影响［D］.济南：山东中医药大学，2017.

宁桂君，补肾中药对高龄肾阴虚型IVF患者AGEs、RAGEmRNA及治疗结局的影响［D］.济南：山东中医药大学，2017.

何军琴，朱萍，李梦元，等.中药序贯周期疗法对高龄卵巢低反应患者在IVF-ET技术中的疗效观察［J］.中国中西医结合杂志，2020，40（9）：1032-1037.

洪艳丽，谈勇，殷燕云，等.益经汤联合高孕激素状态下促排卵方案在高龄女性体外受精-胚胎移植中的应用［J］.中华中医药杂志，2019，34（7）：3315-3319.

康敏霞，崔蕾蕾，黄银娟，等.滋水涵木方对高龄卵巢储备功能下降患者子宫血流参数、内分泌功能及体外受精周期结局的影响［J］.中医学报，2022，37（5）：1092-1097.

李静，滕涛，梁琦，等.中药联合脱氢表雄酮预治疗对高龄卵巢储备正常患者体外受精-胚胎移植结局的影响［J］.中国中西医结合杂志，2016，36（9）：1046-1050.

MA Y J，YUAN L H，XIAO J M，et al.The mechanism of traditional Chinese medicine based on semi-targeted metabolomics to improve IVF outcomes in senile patients［J］.Evid Based Complement Alternat Med，2021，2021：6696305

SONG J Y，GAO D D，CAO X L，et al.The role of traditional Chinese formula Ding-Kun pill （DKP） in expected poor ovarian response women （POSEIDON Group 4） undergoing in vitro fertilization-embryo transfer：A multicenter，randomized，double-blind，placebo-controlled trial［J］.Front Endocrinol （Lausanne），2021，12：675997.

苏嘉文.滋肾养肝活血法对高龄卵巢储备功能下降患者IVF周期结局的影响［D］.广州：广州中医药大学，2018.

SUN J，SONG J Y，DONG Y，et al.Erzhi Tiangui granules improve in vitro fertilization outcomes in infertile women with advanced age［J］.Evid Based Complement Alternat Med，2021，2021：9951491.

连方，宋诗艳.右归胶囊通过JAK2/STAT3通路改善高龄体外受精-胚胎移植女性卵细胞质量［J］.中国中西医结合杂志，2018，38（9）：1068-1072.

吴海萃，张建伟，冯帅，等.六味地黄颗粒对肾阴虚高龄不孕患者IVF结局及卵巢颗粒细胞的影响［J］.山东中医杂志，2019，38（6）：523-529.

WU J，LIU Y，SONG Y，et al.Aging conundrum：A perspective for ovarian aging［J］.Front Endocrinol （Lausanne），2022，13：952471.

史薇，刘敏，王智超，等.补肾养血活血类中药复方调控线粒体稳态治疗卵巢功能减退类疾病的研究进展［J］.中国实验方剂学杂志，2023，29（1）：240-249.

王华伟，唐莉，杨泽星，等.“治未病”思想在辅助生殖中的应用［J］.医学争鸣，2021，12（1）：13-17.

薛立英，高丽，秦雪梅，等.药食同源中药抗衰老研究进展［J］.食品科学，2017，38（15）：302-309.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Protein Modification Omics： A Novel Approach Investigating Mechanisms of Chinese Medicines

Improvement of Uterine Aging by Traditional Chinese Medicine： A Review

Chinese Medicine Regulates Hepatocellular Carcinoma-related Signaling Pathways： A Review

Pathogenesis of Idiopathic Pulmonary Fibrosis and Modulating Effect of Chinese Medicine： A Review

Chinese Medicines Treat Rheumatoid Arthritis via Gut-joint Axis： A Review

Related Author

WANG Lihan

HOU Jingyi

ZHANG Jingjing

YANG Hongjun

WANG Peixuan

JIA Zhicheng

LI Yongqian

WANG Zhe

Related Institution

Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases，Experimental Research Center，China Academy of Chinese Medical Sciences

Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences

First School of Clinical Medicine， Gansu University of Chinese Medicine

Jiangxi University of Chinese Medicine

National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine， Jiangxi University of Chinese Medicine

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰